Healthcare & Life Sciences

From Development to Commercial – Solutions for Biotech Organizations Navigating Critical Transformations

December 9, 2025
Healthcare & Life Sciences

A biopharmaceutical company’s pivotal trial readout and transition to a commercial organization are key inflection points in its corporate evolution. To achieve success around these moments and beyond, multi-stakeholder, external and internal communications must be considered. FTI Consulting’s Healthcare & Life Sciences team takes a deeper look into various scenarios and needs that may arise and has the right skillset to help you navigate these key moments in time.

Related Insights

Contact Us

Robert Stanislaro
Senior Managing Director
[email protected]

Boston CEO Event (4)

Helen O’Gorman
Managing Director
Helen.O’[email protected]

Jim Polson
Senior Managing Director
[email protected]

Jim Polson Quote (2)

Matthew Ventimiglia
Managing Director
[email protected]

Related Articles

4th Annual Shareholder Activism State of the Market

September 8, 2025—4th Annual Shareholder Activism State of the Market Request Report The 4th Annual Shareholder Activism State of the Mark...
Use It or Lose It: U.S. Hydrogen Industry Must Act To Maintain Momentum

July 12, 2025—Key takeaway: Following the passage of the “One Big Beautiful Bill Act”, time is of the essence for hydrogen produce...
Quick Analysis: ‘One Big Beautiful Bill’ Drives More Gas and Batteries, Less Renewables

July 3, 2025—With the recent passage of the “One Big Beautiful Bill” (“OBBB” or the “Legislation”),[1] FTI Consulting’s...
FTI Consulting News Bytes – 12 June 2026

June 12, 2026—FTI Consulting News Bytes From drones to chatbots to humanoid robotics and more, it has been a busy week as business and...
Global Public Affairs Newswire – 12 June 2026

June 12, 2026—Welcome to the latest instalment of FTI Consulting’s fortnightly Global Public Affairs Newswire. This week, we bring y...
ESG+ Newsletter – 11 June 2026

June 11, 2026—In this week’s ESG+ Newsletter, we first dive into updates within the sustainable reporting landscape, as Norges B...